Home › Hidradenitis Suppurativa › Kentucky
Hidradenitis Suppurativa clinical trials in Kentucky
7 studies for Hidradenitis Suppurativa are looking for participants at sites in Kentucky.
Cities in Kentucky
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- Equity Medical, Bowling Green
RecruitingPhase 2
Ages 12 to 17 · All sexes · Updated Nov 13, 2026 · NCT07213973Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US143, Bowling Green
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT06855498A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)
- Site 100, Bowling Green
- Site 116, Owensboro
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 19, 2026 · NCT07766005A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
- Dermatology Specialists Research (DS Research) - Kentucky- Site Number : 8400026, Louisville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 16, 2026 · NCT07225569Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa
- Clinical Site 1, Bowling Green
- Clinical Site 2, Owensboro
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 15, 2026 · NCT07828860Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
- Equity Medical, Llc, Bowling Green
RecruitingPhase 1
Ages 12 to 75 · All sexes · Updated Oct 9, 2026 · NCT07049575A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
- Kentucky Advanced Medical Research LLC, Murray
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Jul 22, 2026 · NCT07384975From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.